Quick Answer: Japan regulates cosmetics under the PMD Act through product classification, licensed business responsibilities, standards, applicable notifications, labelling, advertising and ongoing safety controls. Ordinary standards-compliant cosmetics generally do not require routine product marketing approval, while quasi-drugs follow a separate route. Distinguish a business licence, a product notification and any required product approval, and apply the Japanese rules in force for the actual case.
Understand the framework before choosing a form
Start by identifying the decision each rule governs. Classification determines the product category. Business authorisation determines which operator can perform an activity. Product procedures address the particular item. Standards and labelling govern the product placed on the market. Ongoing controls connect production, stock release and customer reports. These layers interact, but evidence for one layer does not complete the others.
The Japanese PMD Act text published by MHLW provides the national legal framework. Article 2 defines the relevant categories; Articles 12 and 13 distinguish marketing and manufacturing business licences; Article 61 addresses cosmetic container particulars. Read the applicable implementing rules and notices with the Act, and use a qualified Japanese reviewer for a product-specific interpretation.
Prepare a one-page regulatory map showing product identity, category, operators, applicable procedures and outstanding evidence. Use it to brief the brand and factory. A map is especially helpful when several companies use the word “registration” to mean different things and believe another partner has completed the missing work.
| Layer | Question answered | Evidence to retain |
|---|---|---|
| Classification | Is this a cosmetic, quasi-drug or another category? | Dated assessment of composition, purpose and presentation |
| Business licensing | Who may perform the proposed activity? | Verified entity, licence and activity scope |
| Product procedure | Which notification or approval route applies? | Applicable submission and issued records |
| Ongoing compliance | How is the supplied product controlled? | Specifications, release, complaints and change history |
Classify purpose, composition and presentation together
A familiar product format does not establish its legal category. Examine intended use, application area, ingredients, directions and proposed Japanese wording as one package. A product sold as a cosmetic in its home country may need a different assessment when its Japanese name or benefit presentation suggests a quasi-drug purpose. Resolve that issue before treating a cosmetic notification checklist as the route.
The MAH and qualified local reviewer should document the reasoning and any authority consultation needed. Give them the complete proposed pack and digital claims, rather than a simplified internal description. Keep a record of phrases that have been rejected or limited, including the reason, so they do not return through a marketplace listing or translated sales presentation.
Do not describe quasi-drugs as merely stronger cosmetics. Their regulatory route and evidence requirements differ. Equally, do not assume that every product containing a fashionable ingredient is a quasi-drug. The assessment must address the actual product and intended presentation, rather than a slogan or a competitor’s pack.
Distinguish MAH and manufacturing business responsibilities
Identify the Japanese cosmetics marketing authorization holder, often called the MAH, and the entities carrying out relevant manufacturing activities. Their business licences serve different functions. Local packaging, labelling and storage arrangements require attention to the applicable activity scope; a commercial distributor or fulfilment warehouse should not be assumed to cover those operations automatically.
Request the exact legal entities, business addresses, licence references and scope assessment for the supply model. Check which party controls quality and post-market safety procedures and how the overseas factory will provide technical answers. Keep an operational contact and backup for the Japanese team. A named company on an invoice is not sufficient evidence of the responsibilities agreed for the product.
Write the handoffs around real decisions: approval of specifications, acceptance of evidence, stock release, complaint escalation, regulatory correspondence and changes. Agree access to records and a transition process if the brand changes service partners. These practical controls make the legal allocation workable when a batch issue occurs or staff change.
| Workstream | Manufacturer role | Brand and Japanese MAH role |
|---|---|---|
| Technical master | Supply controlled formula, site and specifications | Reconcile product identity and destination assessment |
| Product evidence | Explain relevant tests and manufacturing controls | Assess completeness for intended use and claims |
| Artwork and advertising | Supply accurate technical information | Approve Japanese meaning and claim limits |
| Post-market action | Investigate affected batches and changes | Assess local response and preserve traceability |
Use notification and approval terminology accurately
PMDA’s official FAQ says that cosmetic sales do not require a routine marketing approval application when the product complies with the Standards for Cosmetics. Read that explanation together with the national framework and the applicable notification procedure. It is not a blanket exemption from pre-market responsibilities, and it should not be rephrased as Japanese government endorsement of every cosmetic claim.
For an ordinary cosmetic project, ask the MAH to identify the advance product notifications and associated records required for the actual manufacturing or importing arrangement. Confirm the receiving authority, current form and information requirements. For a quasi-drug or an exceptional product, establish the applicable approval route separately. Do not attach an ordinary cosmetic timeline to a project that has not resolved its category.
Reconcile the submitted identity with the formula, manufacturer and artwork. Retain the approved submission dataset and correspondence. If the team receives a query, route it to the technical reviewer rather than inventing missing information. A notification record should describe the exact product being supplied, not a convenient approximation of it.
Assess the full formula against current Japanese standards
The MHLW English Standards for Cosmetics is labelled a provisional translation. It describes general safety provisions, prohibited and restricted ingredients, and specific controls for preservatives, UV absorbers and tar colours. Use it to understand the structure, then check the current Japanese text and related notices for the assessment. An English document’s availability does not establish that every later amendment has been incorporated.
Give the reviewer a controlled composition record with precise ingredient identities, relevant amounts, functions and manufacturing details. Include information needed to evaluate relevant impurities and intended exposure. Resolve ambiguous trade names with supplier documentation. A raw-material brochure may help identify questions but cannot stand in for a complete formulation assessment.
Record the versions and dates of the rules reviewed, conditions of use, warnings and unresolved questions. The ASEAN ingredient review guide offers a useful organisational comparison for regional projects, but an ASEAN clearance does not establish compliance with Japan. Likewise, general international experience with an ingredient does not override a national restriction.
| Record | Compare with | Common gap |
|---|---|---|
| Composition | Specifications and supplier identities | Trade names without precise composition |
| Product procedure | Approved product master | Different manufacturer or product name |
| Packaging | Japanese copy and final print proof | Reviewed text altered in artwork |
| Claims | Finished-product support and assessed purpose | Overseas promise copied without review |
Review labels and advertising as connected content
Use the current requirements to prepare a Japanese copy sheet for mandatory particulars and relevant directions or precautions. Check the MAH identity, product name, batch marking, ingredient presentation and any applicable expiry or warning requirements with the local reviewer. Do not turn a generic list into a universal declaration that every pack requires exactly the same wording.
Review the final proof at print size and in its intended container geometry. Check variable marking, supplementary labels and readability after application. Ensure the proof remains associated with the same product and formula revision as the regulatory file. Record who authorised the final artwork and what changed after the initial translation.
Assess claims across the package, product page, retail listing, testimonials and creator briefs. Maintain a controlled claim library with evidence references and permitted context. Small changes in translation can materially change meaning. Customer-service scripts should use the same approved directions and cautions as the product presentation.
Build quality and post-market processes into the file
Ask the OEM/ODM cosmetics manufacturer for the specifications, relevant stability and compatibility work, quality information and evidence supporting important claims. Explain how each record relates to the actual formula and pack. Where related-product data is proposed, state the relationship and its limitations for expert assessment rather than assuming all variants are interchangeable.
Use the retrieval questions in our product information file preparation guide to organise the records, while tailoring the file to Japanese duties. Assign document owners, access arrangements, revision controls and backup contacts. A folder full of certificates is only useful if the responsible team can find the current evidence for a particular product and batch.
Connect incoming complaints with product identity, batch and purchase information. Route material reports to the responsible Japanese team and manufacturer for assessment. Preserve investigation outcomes and decisions about affected stock. Routine customer service should not improvise a medical diagnosis or dispose of a report because the product was previously released.
| Stage | Decision | Control record |
|---|---|---|
| Before development lock | Category and intended claims resolved | Approved regulatory brief |
| Before filing | Operators, formula and evidence reconciled | Versioned master and gap log |
| Before release | Applicable procedures and packaging complete | Documented release decision |
| After supply | Reports and proposed changes assessed | Complaint and change history |
Check amendments by their actual effective dates
The MHLW cosmetics and quasi-drugs hub links standards, cosmetic efficacy notices and supporting questions and answers. Use the subject-specific materials relevant to the product instead of assuming that an old industry summary remains complete. Keep the Japanese source references with the assessment and record the date reviewed.
The MHLW 2025 PMD Act amendment hub includes phased implementation materials, including measures taking effect in 2026. Publication, commencement and transition are different events. Have the reviewer determine which provisions affect the product or operator and when, rather than treating the whole amendment as immediately effective or assuming every pharmaceutical reform applies identically to cosmetics.
Older English legal translations can help an international team understand terminology but may lag the operative Japanese framework. A useful review record identifies the current text, implementing rules, relevant notices, effective date and any transition relied upon. Revisit that record before a material change or a new launch, and when a relevant notice is issued.
Control changes before they reach saleable stock
Compare the current and proposed formula, supplier, manufacturing site, product identity, packaging and claims in a documented change request. Identify the affected batches and desired implementation date. The MAH and reviewer should determine the local action and evidence needed before the factory implements the change. A minor commercial edit can still affect product meaning or record consistency.
Keep consignment controls distinct from the product file. The importer and broker must confirm current requirements for the goods actually shipped and reconcile product names, manufacturer and commercial documents. Customs clearance alone does not resolve a composition issue, and a notification record alone does not establish that a damaged batch should be sold.
Our ASEAN notification overview helps explain the importance of national routes in multi-market projects. For manufacturing evidence preparation, contact the project team with the Japanese category assessment, proposed MAH and current gap log. Use that brief to agree what the factory can provide and which decisions require Japanese specialist review.
Frequently asked questions
Is a business licence the same as product approval?
No. A business licence concerns an operator and activity. Product notification or any required approval concerns the particular product and applicable route; both need to be assessed.
Are all cosmetics exempt from pre-market work?
No. Ordinary standards-compliant cosmetics generally avoid routine product marketing approval, but classification, licensed operators, applicable notifications, standards and packaging responsibilities remain.
Can overseas compliance evidence be reused?
It may support the assessment when relevant to the exact product. It does not automatically establish Japanese classification, ingredient compliance, labelling or advertising acceptability.
Which language version should the reviewer rely on?
Use the operative Japanese framework and current notices. English translations aid understanding but may be provisional or older than amendments and implementing provisions.
What needs review after a formula or site change?
Compare the proposed change with the current product record and evidence. Have the Japanese MAH determine the procedural, safety, quality and artwork consequences before implementation.
Last reviewed: 25 October 2026. General planning information only, not product-specific legal, customs or safety advice. Confirm the current Japanese requirements, competent authority, effective dates and applicable transitional provisions with a qualified Japanese reviewer before manufacturing, importing or sale.